This was shown by GCS inhibition with RNA interference (RNAi) or siRNA/shRNA that resulted in MDR1 downregulation in doxorubicin-resistant leukemia cells and also increased head and neck cancer (HNC) cells sensitivity to cisplatin [25]. Here, UGCG is linked to head and neck cancer.